The cost of over-the-counter (OTC) drugs in Japan is set to increase, stirring worries among a significant number of patients who rely on these medicines. This unexpected change has reportedly caused patients to experience strain due to the increased financial burden. The reasons behind this surge in prices and its consequences on public health are yet to be discussed in detail.

In Japan, health expenses are an essential aspect of society, highly regarded by the public due to the country's aging population. The increase in OTC drugs could adversely affect the daily lives of many, especially elderly citizens. Japan's health insurance typically covers prescribed medication, but OTC drugs are usually paid for out-of-pocket. This news will spark discussions about healthcare affordability and how it impacts societal well-being.

In the US and EU, the issue of rising drug costs is an ongoing concern, sparking debates about the role of pharmaceutical companies, insurance, and government policy. The rise in OTC drug prices in Japan parallels these situations and opens up similar points of dialogue about healthcare systems and their affordability.